We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
ATN International
ATNI
$466M
| $2.1M | ﹤0.01% |
37,897
+1,792
| +5% | +$102K |
|
1777
OceanFirst Financial
OCFC
$1.91B
| $2.1M | ﹤0.01% |
82,160
+2,355
| +3% | +$56.7K |
|
1778
Chesapeake Utilities
CPK
$3.2B
| $2.09M | ﹤0.01% |
21,820
+82
| +0.4% | +$7.62K |
|
|
HSII
1779
DELISTED
Heidrick & Struggles
HSII
| $2.09M | ﹤0.01% |
64,172
+3,125
| +5% | +$92K |
|
1780
Workiva
WK
$3.34B
| $2.08M | ﹤0.01% |
49,544
+1,914
| +4% | +$80.6K |
|
|
USCR
1781
DELISTED
U S Concrete, Inc.
USCR
| $2.08M | ﹤0.01% |
49,909
+2,529
| +5% | +$116K |
|
1782
National Presto Industries
NPK
$1B
| $2.07M | ﹤0.01% |
23,436
+1,209
| +5% | +$105K |
|
1783
Westlake Corp
WLK
$10.1B
| $2.07M | ﹤0.01% |
29,520
-1,416
| -5% | -$95.1K |
|
1784
AngioDynamics
ANGO
$625M
| $2.06M | ﹤0.01% |
128,586
+7,207
| +6% | +$110K |
|
1785
Seaboard Corp
SEB
$3.99B
| $2.06M | ﹤0.01% |
484
-3
| -0.6% | -$12.6K |
|
|
EGRX
1786
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.03M | ﹤0.01% |
33,803
+1,516
| +5% | +$90.4K |
|
1787
Tredegar Corp
TG
$270M
| $2.03M | ﹤0.01% |
90,787
+3,356
| +4% | +$70.4K |
|
1788
Magnolia Oil & Gas
MGY
$5.88B
| $2.02M | ﹤0.01% |
160,686
+5,501
| +4% | +$61.6K |
|
1789
Herc Holdings
HRI
$5.58B
| $2.02M | ﹤0.01% |
41,212
+613
| +2% | +$28.6K |
|
1790
MACOM Technology Solutions
MTSI
$22.9B
| $2.01M | ﹤0.01% |
75,655
+1,295
| +2% | +$30.9K |
|
|
MNTV
1791
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.01M | ﹤0.01% |
112,505
+6,429
| +6% | +$113K |
|
1792
AdvanSix
ASIX
$543M
| $2.01M | ﹤0.01% |
100,655
+4,320
| +4% | +$94.4K |
|
1793
Zillow
ZG
$7.5B
| $2M | ﹤0.01% |
43,741
-3,825
| -8% | -$141K |
|
|
APLS
1794
DELISTED
Apellis Pharmaceuticals
APLS
| $2M | ﹤0.01% |
65,248
+2,900
| +5% | +$80.3K |
|
1795
SFL Corp
SFL
$1.61B
| $2M | ﹤0.01% |
137,189
+6,672
| +5% | +$96.5K |
|
1796
TTEC Holdings
TTEC
$126M
| $1.99M | ﹤0.01% |
50,171
+8,023
| +19% | +$351K |
|
|
CBPX
1797
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $1.99M | ﹤0.01% |
54,519
+1,672
| +3% | +$55K |
|
1798
Sturm, Ruger & Co
RGR
$608M
| $1.98M | ﹤0.01% |
42,177
+2,650
| +7% | +$120K |
|
1799
Quanex
NX
$961M
| $1.97M | ﹤0.01% |
115,125
+4,630
| +4% | +$87.1K |
|
|
BNFT
1800
DELISTED
Benefitfocus, Inc.
BNFT
| $1.96M | ﹤0.01% |
89,506
+1,245
| +1% | +$28.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.